Efficacy of florfenicol for the treatment of Staphylococcus intermedius pyoderma in dogs
DOI:
https://doi.org/10.15381/rivep.v32i1.17678Keywords:
antibiotic therapy, bacterial infection, individualized medicine, PK/PD modellingAbstract
The aim of this study was to evaluate the effect of florfenicol treatment at doses of 10 and 20 mg/kg administered IM, in the treatment of canine pyoderma due to Staphylococcus intermedius, using pharmacokinetic/pharmacodynamic modelling (PK/PD). A Monte Carlo simulation of the pharmacokinetic and pharmacodynamic parameters was performed, followed by a PK/PD modelling to determine the efficacy rates in the treatment of bacterial infection, according to the minimum inhibitory concentration (MIC) of S. intermedius, using the range between 0.25 and 2 µg/ml. The probabilities of obtaining the bacteriological eradication index with the 10 mg/kg dose were 97, 77, 7 and 1%, and with the 20 mg/kg dose it was 95, 87, 61 and 7%, according to bacterial MICs of 0.25, 0.5, 1 and 2 µg/ml, respectively. The probability of obtaining a bacteriological cure after treatment with the 10 mg/kg dose decreased significantly for infections caused by microorganisms with MICs higher than 0.5 µg/ml (p<0.01), while for the 20 mg/kg dose kg was with MIC greater than 1 µg/ml (p<0.01). The results show the need to incorporate bacteriological isolation, the determination of MIC and the optimization of therapeutic doses based on bacterial susceptibility in the therapeutic protocol in order to avoid therapeutic failures and, consequently, the increase in the development of microbial resistance.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Emanuely Ramos Tameirão, Bruna Christina Fernandes Soares, Hugo Shisei Toma, Sheila Rezler Wosiacki, Marcos Ferrante
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
AUTHORS RETAIN THEIR RIGHTS:
a. Authors retain their trade mark rights and patent, and also on any process or procedure described in the article.
b. Authors retain their right to share, copy, distribute, perform and publicly communicate their article (eg, to place their article in an institutional repository or publish it in a book), with an acknowledgment of its initial publication in the Revista de Investigaciones Veterinarias del Perú (RIVEP).
c. Authors retain theirs right to make a subsequent publication of their work, to use the article or any part thereof (eg a compilation of his papers, lecture notes, thesis, or a book), always indicating the source of publication (the originator of the work, journal, volume, number and date).